特别提示:包括重组人趋化因子CXCL1(GROα)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:重组人趋化因子CXCL1(GROα)
英文名称:Recombinant Human C-X-C Motif Chemokine 1
产品货号:JN0300
产品规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物表达系统制备,目的基因编码的Ala35-Asn107在C端含有His标签。
CXCL1/GRO alpha质量控制:>95%(还原性SDS-PAGE)。
CXCL1/GRO alpha制剂:冻干品
CXCL1/GRO alpha保存:
冻干蛋白可在-20℃长期保存,室温也可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天。
复溶后建议分装冻存在-20℃,可保存3个月,应避免反复冻融。
CXCL1/GRO alpha复溶:
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存,避免反复冻融。
关于CXCL1/GRO alpha:
Chemokine (C-X-C motif) Ligand 1 Protein (CXCL1) is a growth factor for melanoma cells and a chemotaxin for neutrophils and a member of the CXC chemokine family that is a potent neutrophil attractant and activator and is also active toward basophils. CXCL1 is expressed by macrophages, neutrophils and epithelial cells; it has neutrophil chemoattractant activity. CXCL1 plays a critical no
nredundant role in the development of experimental Lyme arthritis and carditis via CXCR2-mediated recruitment of neutrophils into the site of infection and may also have im
portant pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
根据您的关注的
重组人趋化因子CXCL1(GROα),Recombinant Human C-X-C Motif Chemokine 1,GROα,重组人GROα,重组人趋化因子CXCL1,重组C-X-C Motif Chemokine 1,重组人C-X-C Motif Chemokine 1,rhGROα,重组人趋化因子CXCL1(GROα),重组趋化因子CXCL1,重组GROα,rGROα,JN0300,百奥莱博,,,您可能还对以下产品有需求:
名称:重组人MYDGF
货号:JN0384
规格:10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备,目的基因编码的Ser33-Leu173在N端含有His标签
MYDGF/C19orf10质量控制:>95%(还原性SDS-PAGE)。
MYDGF/C19orf10制剂:冻干品
MYDGF/C19orf10保存:
冻干蛋白可在-20℃长期保存,室温也可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天。
复溶后建议分装冻存在-20℃,可保存3个月,应避免反复冻融。
MYDGF/C19orf10复溶:
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存,避免反复冻融。
关于MYDGF/C19orf10:
Myeloid-derived growth factor (MYDGF) is a secreted protein which belo
ngs to the UPF0556 family. MYDGF was stro
ngly expressed in spleen, prostate and lung, and weakly expressed in the left ventricle and liver. Bone marrow-derived mo
nocyte and paracrine-acting protein promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction (MI). MYDGF stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. It inhibits cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway. MYDGF is involved in endothelial cell proliferation and angiogenesis. It may serve as a prototypical example for the development of protein-ba
sed therapies for ischemic tissue repair.
.jpg)
关注
重组人趋化因子CXCL1(GROα),Recombinant Human C-X-C Motif Chemokine 1,GROα,重组人GROα,重组人趋化因子CXCL1,重组C-X-C Motif Chemokine 1,重组人C-X-C Motif Chemokine 1,rhGROα,重组人趋化因子CXCL1(GROα),重组趋化因子CXCL1,重组GROα,rGROα,JN0300,百奥莱博,,的同时,为您推荐更多您可能感兴趣的产品:
JN0317 重组人趋化因子CCL18(PARC) 10μg|50μg|500μg|1mg
JN1903 重组人半乳糖凝集素7 10μg|50μg|500μg|1mg
JN1911 重组人BCL2L2(Bc1-w) 10μg|50μg|500μg|1mg
JN1955 重组人Stratifin蛋白 10μg|50μg|500μg|1mg
JN1987 重组人C-反应蛋白(CRP) 10μg|50μg|500μg|1mg
JN1997 重组人生长停滞特异性蛋白7(GAS-7) 10μg|50μg|500μg|1mg
JN0527 重组人FLRT1 10μg|50μg|500μg|1mg
.jpg)
本页产品地址:http://www.geilan.com/sell/show-8529564.html